Most research peptides have a reasonably settled mechanism. DSIP does not, and that is precisely what makes it interesting as a research material. Fifty years after its isolation, the peptide still has no confirmed receptor.
What DSIP is
Delta sleep-inducing peptide is a nonapeptide, nine amino acids in length, with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. It was isolated in the 1970s from the cerebral venous blood of rabbits during induced slow-wave sleep, and it was named for the circumstances of that discovery rather than for a demonstrated mechanism.
That naming has caused persistent confusion. The name asserts a function that the subsequent literature has never cleanly confirmed.
The receptor problem
For a peptide to act as a classical signalling molecule, there should be a receptor it binds. For DSIP, no specific receptor has been identified and characterised. This is the central unresolved issue in the field, and it is why Kovalzon's 2006 review in the Journal of Neurochemistry is titled, bluntly, a still unresolved riddle.[1]
Several explanations have been proposed across the literature. DSIP may act through modulation of other systems rather than a dedicated receptor. It may function as a precursor fragment. Reported effects may in some cases reflect experimental artefacts. None of these has been established.
What the published research examines
Early characterisation
Graf and Kastin's 1984 review in Neuroscience and Biobehavioral Reviews consolidated the first decade of work.[3] Pollard's later overview in the European Journal of Anaesthesiology summarised the position from a pharmacological standpoint.[2] Both are useful entry points, and both are notably measured in tone compared with how the peptide is often described elsewhere.
Beyond sleep
A substantial portion of DSIP research has little to do with sleep at all. Reported findings across animal models span stress response, thermoregulation and neuroprotection. A 2021 study in Molecules examined motor function recovery in rats following induced focal stroke, which is representative of the direction much of the recent work has taken.[4]
This breadth is itself informative. A peptide with effects reported across many unrelated systems, and no identified receptor, may be acting through a general mechanism rather than a specific one.
Handling and stability
DSIP is supplied as a lyophilised solid. Standard practice is storage at −20°C protected from light and moisture, with reconstitution in sterile solvent added slowly down the vial wall and gentle swirling rather than vortexing.
Short peptides in solution are susceptible to both aggregation and adsorption onto container surfaces. For a nine-residue peptide at low working concentrations, loss to plasticware is a real and frequently underestimated source of variability between runs. Low-binding tubes are worth considering.
What the literature does not establish
This is the section that matters most for DSIP. There is no confirmed receptor. There is no settled mechanism. Reported effects across the literature are inconsistent between research groups, and several early findings have proved difficult to reproduce.
Study designs vary enormously in species, route, concentration and endpoint measured, which makes cross-study comparison largely unreliable. Anyone working with DSIP should treat the existing literature as a set of open questions rather than a foundation of settled findings.
References
- Kovalzon VM. Delta sleep-inducing peptide (DSIP): a still unresolved riddle. Journal of Neurochemistry. 2006. PMID 16539679
- Pollard BJ. Delta sleep-inducing peptide. European Journal of Anaesthesiology. 2001. PMID 11437870
- Graf MV. Delta-sleep-inducing peptide (DSIP): a review. Neuroscience and Biobehavioral Reviews. 1984. PMID 6145137
- Tukhovskaya EA. Delta Sleep-Inducing Peptide Recovers Motor Function in SD Rats after Focal Stroke. Molecules. 2021. PMID 34500605
Research use only
DSIP is supplied by MMpeptides strictly for laboratory and in vitro research. It is not approved for human or veterinary use, is not a cosmetic or medicinal product, and nothing in this article should be read as describing use in people. Third-party studies are cited for scientific context only. Researchers are responsible for observing all applicable regulations in their jurisdiction.